Jorg Thommes, PhDHead of CMC at Bill & Melinda Gates Medical Research Institute
Dr. rer. nat Jorg Thommes is the Head of CMC at the Bill & Melinda Gates Medical Research Institute in Cambridge, MA. The Institute is a non-profit biotech organization and our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world's poorest people. The Institute’s CMC group is responsible for physical product development, manufacturing, and distribution across the entire portfolio. Prior to joining the Bill & Melinda Gates Medical Research Institute, Dr. Thommes was the Senior Vice President Pharmaceutical Sciences and Technology at Visterra. In this role he was responsible for all aspects of CMC development, manufacturing, and drug supply for Visterra’s products. Prior to the role at Visterra, Dr. Thommes was at Biogen, Inc., where he served among other positions as Senior Vice President, Engineering and Technology, and his responsibilities included process development for all therapeutic modalities, global and site engineering, and manufacturing sciences. Previously, Dr. Thommes was the Director, Protein Purification Development, at IDEC Pharmaceuticals and prior to IDEC, he held a research and teaching position at the Institute of Enzyme Technology at University of Dusseldorf, Germany. He serves on the board of the Recovery of Biological Products conference series and was chairman of that board from 2014 to 2016. Dr. Thommes received a Diplom-Chemiker degree from University of Bonn, Germany, a Doctorate of Natural Sciences from University of Bonn, Germany, and a Habilitation Degree in Biochemical Engineering from University of Dusseldorf, Germany.